In our case–case study the relationship between serum sexual hormone levels and tumor ER, PR and HER2 status was retrospectively studied using data collected from postmenopausal patients treated with breast cancer between 2003 and 2011 in the National Institute of Oncology, Hungary. This evidence concerns the gene ERBB2 and neoplasm.